No abstract available
MeSH terms
-
Antibodies, Monoclonal / adverse effects*
-
Antibodies, Monoclonal, Humanized / adverse effects*
-
Antineoplastic Agents / adverse effects*
-
Carcinoma, Renal Cell / drug therapy
-
Fatal Outcome
-
Humans
-
Kidney Neoplasms / drug therapy
-
Lichen Nitidus / chemically induced*
-
Lichen Nitidus / pathology
-
Male
-
Middle Aged
Substances
-
Antibodies, Monoclonal
-
Antibodies, Monoclonal, Humanized
-
Antineoplastic Agents
-
tremelimumab
-
mogamulizumab